BRIEF published on 05/08/2024 at 12:35, 1 year 10 months ago Zomedica participera à la conférence mondiale annuelle d'EF Hutton Zomedica Santé Vétérinaire Réunions D'investisseurs Conférence EF Hutton NYSE Américain : ZOM
BRIEF published on 05/08/2024 at 12:35, 1 year 10 months ago NanoViricides Announces Promising Results with NV-387 in Potentially Treating Smallpox and Mpox NanoViricides NV-387 Tecovirimat Smallpox Mpox
BRIEF published on 05/08/2024 at 12:35, 1 year 10 months ago NanoViricides annonce des résultats prometteurs avec le NV-387 dans le traitement potentiel de la variole et de la Mpox NanoViricides NV-387 Tecovirimat Variole Mvariole
BRIEF published on 05/08/2024 at 12:35, 1 year 10 months ago Résultats Positifs pour l'Essai Phase 3 SOLARIS sur l’Olanzapine Schizophrénie Medincell TEV-‘749 SOLARIS Olanzapine
BRIEF published on 05/08/2024 at 12:35, 1 year 10 months ago Positive Results for the SOLARIS Phase 3 Trial of Olanzapine Schizophrenia Medincell SOLARIS Olanzapine TEV-'749
BRIEF published on 05/08/2024 at 12:20, 1 year 10 months ago Holcim Shareholders Approve Proposals at 2024 AGM Corporate Governance Dividend Increase Board Elections Shareholder Approvals Holcim AGM 2024
BRIEF published on 05/08/2024 at 12:20, 1 year 10 months ago Les actionnaires de Holcim approuvent les propositions lors de l'AGA 2024 Gouvernance D'Entreprise Augmentation Du Dividende Élections Du Conseil D'administration Approbations Des Actionnaires Assemblée Générale Holcim 2024
BRIEF published on 05/08/2024 at 12:05, 1 year 10 months ago Cannovation Clinical Research Partners Launches, Aiming to Revolutionize Cannabinoid-Based Therapeutics Drug Development Biopharmaceutical Innovation Cannovation Clinical Research Cannabinoid-based Therapeutics Commercialization Strategies
BRIEF published on 05/08/2024 at 12:05, 1 year 10 months ago Lancement de Cannovation Clinical Research Partners, visant à révolutionner les thérapies à base de cannabinoïdes Développement De Médicaments Recherche Clinique Cannovation Produits Thérapeutiques À Base De Cannabinoïdes Innovation Biopharmaceutique Stratégies De Commercialisation
BRIEF published on 05/08/2024 at 12:05, 1 year 10 months ago Cerrado Gold Inc. Receives Cease Trade Order from Ontario Securities Commission Cerrado Gold Inc. OSC FFCTO Financial Delay Securities Trading Prohibition
Published on 03/12/2026 at 13:16, 43 minutes ago Reeflex Solutions Inc. Provides Bi-Weekly Status Update on MCTO
Published on 03/12/2026 at 13:00, 59 minutes ago Justera Announces Director and Interim CEO Appointments
Published on 03/12/2026 at 12:30, 1 hour 29 minutes ago Nextech3D.ai Signs Three-Year Enterprise 3D Modeling and Augmented Reality E-Commerce Contract Valued at Approximately $175,000
Published on 03/12/2026 at 12:30, 1 hour 29 minutes ago Orogen Royalties Announces Non-Brokered Private Placement of up to $10 Million
Published on 03/12/2026 at 13:45, 14 minutes ago Vietnam Airlines Steps Up Market Promotion Efforts in Europe
Published on 03/12/2026 at 13:20, 38 minutes ago Eightco (NASDAQ: ORBS) Secures $125M in Institutional Commitments Led by Bitmine (NYSE: BMNR), Cathie Wood's ARK Invest, and Payward to Expand into Next Generation Technology
Published on 03/12/2026 at 13:05, 53 minutes ago Phemex TradFi Hits $10B Monthly Volume, Advancing Cross-Market Trading Infrastructure
Published on 03/12/2026 at 13:00, 59 minutes ago Galimedix Therapeutics earns milestone payment in ophthalmology partnership with Théa Open Innovation
Published on 03/12/2026 at 11:59, 2 hours ago Aperam added to BEL 20 index by Euronext following 2026 annual review
Published on 03/12/2026 at 10:55, 3 hours 3 minutes ago Déclaration des transactions sur actions propres réalisées le 09/03/2026
Published on 03/12/2026 at 10:55, 3 hours 3 minutes ago Statement of transactions in own shares on March 9th, 2026
Published on 03/12/2026 at 08:30, 5 hours 29 minutes ago Claude Bernard lance Claude Bernard Compléments alimentaires en partenariat avec Synadiet
Published on 03/12/2026 at 07:30, 6 hours 29 minutes ago Biophytis-LynxKite Alliance Expands to Turbocharge AI-driven drug discovery for next generation longevity therapeutics
Published on 03/12/2026 at 07:30, 6 hours 29 minutes ago Biophytis et LynxKite renforcent leur alliance pour accélérer la découverte de médicaments dédiés à la longévité grâce à l’IA
